Protalix BioTherapeutics PLX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 2.22 | 88.09 | 28.21 | 0.12 | 2,131 | 2 |
| 2025Q2 | 1.48 | 91.35 | 30.15 | 0.04 | 1,172 | 0 |
| 2025Q1 | 2.56 | 111.25 | 68.13 | -0.20 | -4,145 | -4 |
| 2024Q4 | 1.88 | 98.46 | 0.36 | 7,209 | 6 | |
| 2024Q3 | 1.02 | 96.35 | 0.16 | 3,991 | 3 | |
| 2024Q2 | 1.17 | 127.40 | 12.53 | -0.12 | -2,427 | -2 |
| 2024Q1 | 1.26 | 111.81 | 11.07 | -0.24 | -4,856 | -5 |
| 2023Q4 | 1.78 | 99.35 | 12.23 | -0.28 | -5,615 | -6 |
| 2023Q3 | 1.66 | 127.33 | 13.35 | -0.08 | -1,887 | -2 |
| 2023Q2 | 2.00 | 96.48 | 0.92 | 20,421 | 19 | |
| 2023Q1 | 2.10 | 107.52 | -0.20 | -2,459 | -3 | |
| 2022Q4 | 1.37 | 97.46 | -0.28 | -2,495 | -4 | |
| 2022Q3 | 1.04 | 106.66 | -0.32 | -3,125 | -4 | |
| 2022Q2 | 1.09 | 117.28 | -0.44 | -5,524 | -5 | |
| 2022Q1 | 1.06 | 112.11 | -0.20 | -1,870 | -2 | |
| 2021Q4 | 0.83 | 99.08 | -0.56 | -5,706 | -7 | |
| 2021Q3 | 1.33 | 103.23 | -0.36 | -1,885 | -4 | |
| 2021Q2 | 1.91 | 100.10 | -1.00 | -9,166 | -11 | |
| 2021Q1 | 4.46 | 111.63 | -0.56 | -3,705 | -5 | |
| 2020Q4 | 3.63 | 97.29 | 0.12 | 2,839 | 0 |